STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 54 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,000 | -80.6% | 2,937 | -72.2% | 0.00% | – |
Q2 2021 | $31,000 | +121.4% | 10,559 | +105.7% | 0.00% | – |
Q1 2021 | $14,000 | +27.3% | 5,132 | +15.0% | 0.00% | – |
Q4 2020 | $11,000 | – | 4,461 | +9813.3% | 0.00% | – |
Q3 2020 | $0 | – | 45 | -27.4% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 62 | -96.2% | 0.00% | – |
Q1 2020 | $3,000 | -66.7% | 1,612 | -61.7% | 0.00% | – |
Q4 2019 | $9,000 | +350.0% | 4,210 | +341.3% | 0.00% | – |
Q3 2019 | $2,000 | -50.0% | 954 | -27.8% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 1,321 | +45.3% | 0.00% | – |
Q1 2019 | $5,000 | – | 909 | +18080.0% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 5 | -96.9% | 0.00% | – |
Q4 2017 | $1,000 | -92.9% | 159 | -91.9% | 0.00% | – |
Q3 2017 | $14,000 | +1300.0% | 1,971 | +2563.5% | 0.00% | – |
Q2 2017 | $1,000 | – | 74 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |